Conflicts of Interest Australia COVID Policy [Part 1]

on October 30, 2021 IN CONflict$

Updated:8 months ago
Reading Time:20Minutes
Post Words:6956Words

Can someone please explain to me why we are ignoring this?
(Other than the funded-by-Pharma media telling us to?)

👀 CONFLICTS OF INTEREST
in Australian Vaccination Policies

Dr Katie ATTWELL

Member of Immunisation Coalition^{⁽⁰¹⁾ Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/} , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google ^{⁽⁰²⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding}.
Part of a team conducting an evaluation of the “I Immunise” campaign, funded through an unrestricted grant from vaccine manufacturer Sanofi-Pasteur^{⁽⁰³⁾ Katie Attwell of “I Immunise” Campaign: https://theconversation.com/vaccinations-are-a-vital-part-of-ethical-alternative-lifestyles-22385}

Prof Kristine MACARTNEY

$65,330,038 in government grants covering 2020-2023.

Yes: 65 MILLION DOLLARS IN GRANTS TO MACARTNEY.

She is also a member of the Advisory Committee on vaccines (ACV) of the Therapeutic Goods Administration (TGA). Prof Kristine Macartney has also acted as an expert consultant to the World Health Organisation (WHO).

She was also one of the contributing authors of a peer-reviewed paper entitled “Constructing an ethical framework for priority allocation of pandemic vaccines.” Read paper here: https://doi.org/10.1016/j.vaccine.2020.12.053

Prof Kristine Macartney was chosen to represent the government in the NSW Supreme Court hearings.

Director of National Centre for Immunisation Reseasrch & Surveillance (NCIRS) ^{⁽⁰⁴⁾ Kristine Macartney Director of NCIRS: http://www.ncirs.org.au/our-people/executive-management-team}
Presentation at “International Vaccine conference”, where travel was sponsored ^{⁽⁰⁵⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Ex-officio Member of ATAGI ^{⁽⁰⁶⁾ ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members}
In 2018, member of ATAGI’s “Influenza Working Party” which prepares advice for ATAGI^{⁽⁰⁷⁾ ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf}
Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia ^{⁽⁰⁸⁾ ATAGI’s Pertussis Working Party: https://www.health.gov.au/sites/default/files/pertussis-working-party.pdf}
Member of ATAGI’s “HPV working Party” which prepare advice on the epidemiology of HPV and potential vaccination strategies in Australia ^{⁽⁰⁹⁾ ATAGI’s HPV Working Party: https://www.health.gov.au/sites/default/files/hpv-working-party.pdf}
Member of ATAGI’s COVID-19 Working Group ^{⁽¹⁰⁾ ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members}which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.

Prof Ian BARR

Member of Immunisation Coalition ^{⁽¹¹⁾ Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google ^{⁽¹²⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding}
Deputy Director of the WHO Collaborating Centre for Reference and Research on Influenza at the Doherty Institute, where he has had over 35 years’ experience in biological research and development in academic institutions and at CSL on various topics such as vaccine development ^{⁽¹³⁾ Doherty Institute, Ian Barr: https://www.doherty.edu.au/people/dr-ian-barr “35 years experience in biological research and development in academic institutions and at ACSL on various topics such as vaccine development}
From 2015 to 2016 and in 2007, was on the Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines ^{⁽¹⁴⁾ Previous Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines: https://proxy-redirect.netlify.app/influenza/vaccines/virus/temporary_advisors_home/en/}

Show more (expand)

Show less (contract)

Dr Tony BARTONE

Former President of the Australian Medical Association^{⁽¹⁵⁾ AMA Board Members: https://ama.com.au/board}(resigned late 2020 after 2 years).
Member of Immunisation Coalition^{⁽¹⁶⁾ Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/ ,}which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google ^{⁽¹⁷⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding .}

A/Prof Christopher BLYTH

Investigator on a pneumonia/meningitis study in Papua New Guinea. Grant received by employer (The University of Western Australia) from Pfizer^{⁽¹⁸⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}
Co-Director of Wesfarmers Centre for Vaccines and Infectious Diseases; Telethon Kids ^{⁽¹⁹⁾ Telethon Kids Institute, Co-Director: https://www.telethonkids.org.au/contact-us/our-people/b/christopher-blyth/}, which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi ^{⁽²⁰⁾ Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6}
Co-Chair of ATAGI’s COVID-19 Working Group^{⁽²¹⁾ ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members} which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Co-Chair of Australian Technical Advisory Group on Immunisation (ATAGI). ^{⁽²²⁾ ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members}
Member of COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Board^{⁽²³⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}

Show more (expand)

Show less (contract)

Prof Robert BOOY

Medical Advisor of Meningococcal Australia ^{⁽²⁴⁾ Meningococcal Aust Advisor Robert Booy: http://www.meningococcal.org.au/support ,} which has received funds from vaccine manufacturers GSK and Pfizer ^{⁽²⁵⁾ Meningococcal Aust funding: http://www.meningococcal.org.au/support}
Was Head of Clinical Research at the National Centre for Immunisation Research & Surveillance 2005 to 2019 ^{⁽²⁶⁾ Robert Booy Head of NCIRS: https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/robert-booy.html (note: web link has since been removed) – see ref [54] – impparty}
Previously Chair, currently Director and Scientific Advisory Member of the Immunisation Coalition ^{⁽²⁷⁾ Immunisation Coalition Board: https://www.immunisationcoalition.org.au/about-us/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google ^{⁽²⁸⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding}.
In 2009, Robert Booy was a co-author of an “Influenza Vaccine trial” which was funded by CSL^{⁽²⁹⁾ Robert Booy vaccine manufacturer funding: https://www.sciencedirect.com/science/article/pii/S0264410X16307101?via%3Dihub#s0095}
He received funding from CSL, Roche, Sanofi Pasteur, GSK and Pfizer to conduct research or attend and present at scientific meetings ^{⁽³⁰⁾ Robert Booy vaccine manufacturer funding: https://www.sciencedirect.com/science/article/pii/S0264410X16307101?via%3Dihub#s0095}
Member of Friends of Science in Medicine ^{⁽³¹⁾ Friends of Science (FSM) Members: https://www.scienceinmedicine.org.au/who-are-we/who-are-our-friends/our-friends/}, which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 ^{⁽³²⁾ Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings}

Show more (expand)

Show less (contract)

A/Prof Julia BROTHERTON

Co-Author of the Department of Health’s report “Planning for human papillomavirus vaccines in Australia”. This is the report of a meeting convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 12 December 2003, bringing together representatives from eight Australian research groups involved in HPV research, and vaccine manufacturers with HPV vaccine candidates. The meeting was supported by vaccine manufacturers CSL Pharmaceuticals and Glaxo SmithKline ^{⁽³³⁾ Department of Health research group for HPV vaccine: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-cdi-2004-cdi2802-htm-cdi2802p.htm}

Prof Allen CHENG

Director of the Infection Prevention and Healthcare Epidemiology unit at Alfred Health ^{⁽³⁴⁾ Allen Cheng at Alfred Health: https://www.alfredhealth.org.au/find-a-doctor/bio/dr-allen-cheng}, which has received payments from vaccine manufactureres Biocryst, George Clinical, Gilead, GSK and Merck ^{⁽³⁵⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}, and has an appointment in the School of Public Health and Preventive Medicine at Monash University ^{⁽³⁶⁾ Allen Cheng at Alfred Health: https://www.alfredhealth.org.au/find-a-doctor/bio/dr-allen-cheng .}
Co-Chair of ATAGI.^{⁽³⁷⁾ ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members}
Member of the COVID-19 Vaccine & Treatments for Australia – Scientific & Industry Technical Advisory Group^{⁽³⁸⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Co-Chair of ATAGI’s COVID-19 Working Group ^{⁽³⁹⁾ ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members} which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Deputy Chief Health Officer of Victoria ^{⁽⁴⁰⁾ Deputy Chief Health Officer of Victoria, Allen Cheng: https://www.parliament.vic.gov.au/paec/inquiries/article/4554} and influential on coronavirus policy.
Therapeutic Goods Administration (TGA) Advisory Committee on infectious diseases and biostatistics ^{⁽⁴¹⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Site Investigator for a number of infectious disease studies via Alfred Health, which has received payments from vaccine manufacturers Biocryst, George Clinical, Gilead, GSK and Merck ⁽⁴²⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf
Chief Investigator for influenza surveillance (FluCAN Surveillance System) ^{⁽⁴³⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
In 2018 Chair of the Influenza Working Party which prepares advice for ATAGI^{⁽⁴⁴⁾ ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf}
His team has recently received $1.7M from federal governments National Health & Medical Research Council (NHMRC), Refer to NHMRC section below for COI, towards research into how influenza virus infection results in severe illness and death in Australia ^{⁽⁴⁵⁾ Govt announcement $1.7M to Allen Cheng: https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/press-conference-in-melbourne-about-covid-19}

Show more (expand)

Show less (contract)

Peter COSTELLO

Chairman of the Board of Guardians of the Future Fund ^{⁽⁴⁶⁾ Peter Costello Chairman of Future Fund: https://www.futurefund.gov.au/about-us/who-we-are/board-of-guardians}, an Australian government investment fund, with over 2 billion dollars worth of shares in pharmaceutical and vaccine manufacturers i.e. CSL, Johnson and Johnson, Pfizer, Novartis and Merck ^{⁽⁴⁷⁾ Futurefund Investors as at June 2020: https://www.futurefund.gov.au/-/media/future-fund—documents/largest-listed-equity-holdings/20200630—top-100-largest-listed-equity-holdings.ashx?la=en&hash=AA01CDFBEAA52A0D939137EDC9FA55B1969BA317 .} The Future Funds investment in pharmaceutical and vaccine manufacturers has doubled from $1 billion to $2 billion during the coronavirus situation.
Non-Executive Chairman of Nine Entertainment Co. ^{⁽⁴⁸⁾ Peter Costello Chairman of Nine Entertainment Co: https://www.news.com.au/finance/peter-costello-becomes-chairman-of-nine-entertainment/news-story/92f3dfd6cc3386e49b3855640f07c767}
Nine Entertainment own newspapers “the Sydney Morning Herald” and “The Sun Herald” ^{⁽⁴⁹⁾ Nine Entertainment Newspapers: https://www.nineforbrands.com.au/ad-specs/print-and-magazines/, who were/are instrumental in “anti-vax” labelling ⁽⁵⁰⁾Sydney Morning Herald “Anti-vaxxer movement”: https://www.smh.com.au/topic/anti-vaxxer-movement-1mnk .}

A/Prof Nigel CRAWFORD

Currently Director of Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC) at Murdoch Children’s Research Institute^{⁽⁵¹⁾ Nigel Crawford Group Leader at MCRI: https://www.mcri.edu.au/users/dr-nigel-crawford}, which has received funding from Vaccination and Immunisation Research Group from Novartis Vaccines, GSK and Sanofi ^{⁽⁵²⁾Murdoch Children’s Research Institute Funding & collaboration through VIRGo: https://www.mcri.edu.au/research/themes/infection-and-immunity/vaccine-and-immunisation-research-group-virgo Click on “Funding & Collaborations” … Click for full citation ⁽⁵³⁾ ATAGI Conflicts of Interest – 2015 document (now removed from ATAGI website) – Download PDF from imoparty.com}
In 2014 was appointed to ATAGI ^{⁽⁵⁴⁾ Nigel Crawford Group Leader at MCRI: https://www.mcri.edu.au/users/dr-nigel-crawford}
Member of ATAGI’s COVID-19 Working Group^{⁽⁵⁵⁾ ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members} which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Previously Director of The Influenza Specialist Group ^{⁽⁵⁶⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}, which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi ^{⁽⁵⁷⁾ Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/}.

Show more (expand)

Show less (contract)

A/Prof Margie DANCHIN

Member of Immunisation Coalition ^{⁽⁵⁸⁾ Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google^{⁽⁵⁹⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding .}
Group Leader of Vaccine Updake at Murdoch Children’s Research Institute (MCRI) ⁽⁶⁰⁾ MCRI Member Margie Danchin : https://www.mcri.edu.au/users/dr-margaret-danchin
She is also promoting COVID-19 vaccination amongst elderly and children ^{⁽⁶¹⁾ Margie Danchin promoting COVID-19 vaccination: https://theconversation.com/covid-19-vaccines-could-go-to-children-first-to-protect-the-elderly-147899 .}

Laureate Prof Peter DOHERTY

The Doherty Institute for Infection & Immunity is named in honour of Patron, Laureate Professor Peter Doherty, winner of the 1996 Nobel Prize ^{⁽⁶²⁾ Doherty Institute named after Peter Doherty: https://www.doherty.edu.au/about/overview}, where Peter Doherty is still active in science and involved in large, grant-funded programs at both institutions, he commutes between St Jude Children’s Research Hospital in Memphis and the Doherty Institute where he now spends most of his time ⁽⁶³⁾ Peter Doherty: https://www.doherty.edu.au/about/laureate-professor-peter-doherty .
The Peter Doherty Institute is also in collaboration with Vaccine and Immunisation Research Group/Murdoch Children’s Research Institute^{⁽⁶⁴⁾Murdoch Children’s Research Institute Funding & collaboration through VIRGo: https://www.mcri.edu.au/research/themes/infection-and-immunity/vaccine-and-immunisation-research-group-virgo Click on “Funding & Collaborations” … Click for full citation} which has received funding from vaccine manufacturers GSK, Janssen, Merck, Novavax, Sanofi and Sequiris ^{⁽⁶⁵⁾Murdoch Children’s Research Institute Funding & collaboration through VIRGo: https://www.mcri.edu.au/research/themes/infection-and-immunity/vaccine-and-immunisation-research-group-virgo Click on “Funding & Collaborations” … Click for full citation}.
The Peter Doherty Institute have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19^{⁽⁶⁶⁾ Doherty Institute provides modelling for COVID-19 response: https://www.doherty.edu.au/news-events/news/covid-19-modelling-papers}.
Peter Doherty is a member of Friends of Science in Medicine ^{⁽⁶⁷⁾ Friends of Science (FSM) Members: https://www.scienceinmedicine.org.au/who-are-we/who-are-our-friends/our-friends/}, which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 ^{⁽⁶⁸⁾ Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings}

Show more (expand)

Show less (contract)

A/Prof Katie FLANAGAN

Is affiliated to Monash University ^{⁽⁶⁹⁾ Katie Flanagan affiliated with Monash University: https://katieflanagan.net/profile .}
In the last 10 years has been involved in research projects awarded in excess of AU$30 million, includes grants from NHMRC and Bill and Melinda Gates Foundation^{⁽⁷⁰⁾ Katie Flanagan grant funding: https://katieflanagan.net/research-grants .}
Former member of Influenza Vaccine Advisory Board, travel paid for by vaccine manufacturers Sanofi and Seqirus ^{⁽⁷¹⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Member of ATAGI’s COVID-19 Working Group ^{⁽⁷²⁾ ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members} which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.
Presenter at a number of conferences in clinical infectious diseases sponsored by vaccine manufacturer Pfizer ^{⁽⁷³⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Former member of a number of vaccine advisory boards for the influenza vaccine^{⁽⁷⁴⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}

Show more (expand)

Show less (contract)

Prof Ian FRAZER

Co-Inventor of Gardasil vaccine against HPV, (patent with vaccine manufacturer CSL and The University of QLD) ^{⁽⁷⁵⁾ CSL manufacturer of Gardasil vaccine: https://www.epo.org/news-events/events/european-inventor/finalists/2015/frazer.html}and he receives royalties from HPV vaccine sales in the developed world^{⁽⁷⁶⁾ Ian Frazer receives royalties from Gardasil: https://theconversation.com/catch-cancer-no-thanks-id-rather-have-a-shot-7568}
Member of Friends of Science in Medicine ^{⁽⁷⁷⁾ Friends of Science (FSM) Members: https://www.scienceinmedicine.org.au/who-are-we/who-are-our-friends/our-friends/} , which supported “No Jab, No Pay” at the Senate Hearing in Nov 2015 ^{⁽⁷⁸⁾ Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings}

Jane HALTON

Adviser to Prime Minister Scott Morrison on the government’s National COVID-19 Coordination Commission ^{⁽⁷⁹⁾ National COVID-19 Commission (Advisory Board) Commissioners and Key Staff – Jane Halton https://www.pmc.gov.au/ncc/who-we-are}
She is Chair of the Coalition for Epidemic Preparedness Innovations (CEPI)^{⁽⁸⁰⁾ Chair of CEP – Jane Halton – https://cepi.net/about/whoweare/ , which has funded $388M to COVID-19 vaccine manufacturer Novavax ⁽⁸¹⁾CEPI funds Novavax: https://novavax.com/about-us#our-partners}which is being trialled in Australia ^{⁽⁸²⁾ Novovax being trialed in Australia – https://www.nejm.org/doi/full/10.1056/NEJMoa2026920?query=featured_home}
She is pushing for COVID “No Jab, No Play” policy to be adapted to adults ^{⁽⁸³⁾ Jane Halton radio interview pushing for COVID No Jab No Play: https://www.4bc.com.au/push-from-medical-experts-to-make-future-covid-19-vaccine-compulsory/}
She is Director of Crown Resorts ^{⁽⁸⁴⁾ Jane Halton Director of Crown Resorts: https://www.crownresorts.com.au/About-Us/Board-of-Directors} , which is the COVID-19 quarantine facility in Victoria ^{⁽⁸⁵⁾ Crown Resort COVID quarantine facility in VIC: https://www.theage.com.au/national/victoria/high-security-as-international-arrivals-to-melbourne-taken-to-crown-for-quarantine-20200329-p54ex1.html}
Her husband, Trevor Sutton, was the Deputy for Australian Statistician of the Australian Bureau of Statistics (ABS) and sits on the advisory committee of Institute for Health Metrics & Evaluation (IHME) ^{⁽⁸⁶⁾ Trevor Sutton at ABS: http://www.healthdata.org/about/trevor-sutton} of which Jane Halton sits on the board ^{⁽⁸⁷⁾ Jane Halton on Board of IHME: http://www.healthdata.org/about/governance/board} . In 2007, the IHME received funding from Bill & Melinda Gates Foundation ^{⁽⁸⁸⁾ IHME and Bill & Melinda Gates Foundation: http://www.healthdata.org/about/history Refer to 2007}
In 2016, The ABS’s data collection and survey systems was awarded to Accenture^{⁽⁸⁹⁾ ABS awarded to Accenture: https://www.govtechreview.com.au/content/gov-tech/news/abs-engages-accenture-for-improved-data-collection-511127082}, which is in direct partnership with ID2020 agenda and GAVI ^{⁽⁹⁰⁾ Accenture & ID2020 agenda with GAVI: https://id2020.org/alliance .}

Show more (expand)

Show less (contract)

Dr David HAWKES

Is the Director – Meleculator Biology and Viochemistry of VCS Foundation (Victorian Cytology Service) ^{⁽⁹¹⁾ David Hawkes Director of VCS: https://www.vcs.org.au/about-us/executive-team/dr-david-hawkes/}, which promotes HPV vaccination.
The VCS research centre, known as C4, receives funds from National Health & Medical Research Council^{⁽⁹²⁾ VCS funed by NHMRC: https://www.vcs.org.au/}
Member of Friends of Science (FSM) ^{⁽⁹³⁾ Friends of Science (FSM) Members: https://www.scienceinmedicine.org.au/who-are-we/who-are-our-friends/our-friends/}which supported “No Jab, No Pay” bill at the Senate Hearing in Nov 2015 ^{⁽⁹⁴⁾ Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings}
Administrator with Stop the Australian Vaccination Network (SAVN) ^{⁽⁹⁵⁾ PHAA 2014 Conference, promoting SAVN , ⁽⁹⁶⁾ Transcript “No Jab, No Pay” Senate Inquiry Hearing in 2015}, which supported “No Jab, No Pay” Senate Inquiry Hearing in 2015^{⁽⁹⁷⁾ Members of Stop the AVN [SAVN] – Patrick Stokes, Submission at No Jab No Play Senate Inquiry 2015 – PDF}. 👀

Show more (expand)

Show less (contract)

Prof Anne KELSO

Collaborates with WHO Influenza and Essential Regulatory Laboratories ^{⁽⁹⁸⁾ World Health Organisation (WHO), Anne Kelso: https://www.who.int/influenza/gisrs_laboratory/collaborating_centres/collabcentres/en/}
CEO of National Health & Medical Research Council^{⁽⁹⁹⁾ NHMRC, Anne Kelso: https://www.nhmrc.gov.au/about-us/leadership-and-governance/senior-executive-and-leadership-team}
From 2007 to 2015 was on the Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines ^{⁽¹⁰⁰⁾ Previous Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines: https://proxy-redirect.netlify.app/influenza/vaccines/virus/temporary_advisors_home/en/}.
Had an undisclosed number of shares in vaccine manufacturer CSL where she claimed she bought well before 2007^{⁽¹⁰¹⁾“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s … Click for full citation}
In 2009, she helped draw up Australia’s response to the swine flu outbreak ^{⁽¹⁰²⁾“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s … Click for full citation}. CSL was given a $131 million federal government contract to produce the nation’s entire stockpile of swine flu vaccine in 2009 ^{⁽¹⁰³⁾“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s … Click for full citation.}

Show more (expand)

Show less (contract)

Dr Omar KHORSHID

Current President of the Australian Medical Association ^{⁽¹⁰⁴⁾ AMA’s President Dr Omar Khorshid: https://ama.com.au/about/board .}
The AMA is affiliated with the Immunisation Coalition ^{⁽¹⁰⁵⁾ Immunisation Coalition’s Network: https://www.immunisationcoalition.org.au/our-network/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck and Google ^{⁽¹⁰⁶⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding .}
Omar has stated “vaccinating the whole of the population is the only way “to survive” coronavirus coming to our shores”. ^{⁽¹⁰⁷⁾ AMA’s President Dr Omar Khorshid article on COVID vaccination: https://www.theaustralian.com.au/breaking-news/ama-president-omar-khorshid-on-australias-only-way-to-stay-covid-free/news-story/2003d28a98a48071616f7a26f0837486 .}

Dr Stephen Bernard LAMBERT

Chair of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance ^{⁽¹⁰⁸⁾ NCIRS Scientific Advisory Committee: https://www.ncirs.org.au/funding-and-governance/scientific-advisory-committee .}
Has been involved in influenza and pertussis safety studies where he received grants from Sanofi and Seqirus ^{⁽¹⁰⁹⁾ “The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Paris”, 2012-2015: https://academic.oup.com/cid/article/68/3/402/5202330 .}

Prof Helen MARSHALL

ATAGI member at the time, Helen Marshall was also Lead Investigator on a GlaxoSmithKline funded Bexsero meningococcal B vaccine trial in South Australia^{⁽¹¹⁰⁾ “South Australia leads nation with Australian-first Meningococcal B study” The University of Adelaide, 13th Dec 2016: https://www.adelaide.edu.au/news/news89822.html ⁽¹¹¹⁾A Meningococcal B Program for South … Click for full citation}
Member of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance ^{⁽¹¹²⁾ NCIRS Scientific Advisory Committee: https://www.ncirs.org.au/funding-and-governance/scientific-advisory-committee}.
Researcher on clinical trials funded by vaccine manufacturer GSK, Novartis, Pfizer, Merck, Novovax, and Sanofi ^{⁽¹¹³⁾ ATAGI Conflicts of Interest – 2015 document (now removed from ATAGI website) – Download PDF from imoparty.com ⁽¹¹⁴⁾“The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Paris”, 2012-2015: https://academic.oup.com/cid/article/68/3/402/5202330 .}
Member of Friends of Science in Medicine^{⁽¹¹⁵⁾ Friends of Science (FSM) Members: https://www.scienceinmedicine.org.au/who-are-we/who-are-our-friends/our-friends/}, which supported “No Jab, No Pay” bill at the Senate Hearing in Nov 2015 ^{⁽¹¹⁶⁾ Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings}

Show more (expand)

Show less (contract)

Prof Peter MCINTYRE

Former Director of National Centre for Immunisation Research & Surveillance 2005 to 2017 ^{⁽¹¹⁷⁾ Former Director of NCRIS, Peter McIntyre: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-cdieab-bio-mcintyre.htm}
Ex-officio member of ATAGI from 1999-2017 and from 2005 to 2017 National Immunisation Committee (responsible for implementation of immunisation programs) ^{⁽¹¹⁸⁾ Peter McIntyre ex-officio member of ATAGI: https://www.who.int/immunization/sage/meetings/bio_mcintyre/en/}.
Member of ATAGI’s “Pertussis Working Party” which prepared advice on the epidemiology of pertussis and potential vaccination strategies in Australia ^{⁽¹¹⁹⁾ ATAGI’s Pertussis Working Party: https://www.health.gov.au/sites/default/files/pertussis-working-party.pdf}
In 2018 Member of the “Influenza Working Party” which prepared advice for ATAGI ^{⁽¹²⁰⁾ ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf}
In 2003, Prof McIntyre was involved with the inception of HPV vaccination in Australia. He was instrumental in coordinating the meeting with Julia Brotherton which was funded by vaccine manufacturers GSK and CSL ^{⁽¹²¹⁾ Planning for human papillomavirus vaccines in Australia, Peter McIntyre: https://www1.health.gov.au/internet/main/publishing.nsf/content/cda-pubs-cdi-2004-cdi2802-htm-cdi2802p.htm}
The ATAGI Declarations of Interest document from 2015 states that Prof McIntyre has been associated with grant funding from GSK, Pfizer, Merck, National Health & Medical Research Council and ARC ^{⁽¹²²⁾ ATAGI Conflicts of Interest – 2015 document (now removed from ATAGI website) – Download PDF from imoparty.com}

Show more (expand)

Show less (contract)

Prof Jodie McVERNON

In 2018 Member of the “Influenza Working Party” which prepares advice for ATAGI ^{⁽¹²³⁾ ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf}
Member of ATAGI’s “Pertussis Working Party” which prepare advice on the epidemiology of pertussis and potential vaccination strategies in Australia ^{⁽¹²⁴⁾ ATAGI’s Pertussis Working Party: https://www.health.gov.au/sites/default/files/pertussis-working-party.pdf}
Director of Influenza Specialist Group^{⁽¹²⁵⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi ^{⁽¹²⁶⁾ Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/ .}
Received funding from the Australian Research Council (ARC) for vaccine clinical trial investigations ^{⁽¹²⁷⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}
Travel covered to attend a number of workshops and symposiums sponsored by vaccine companies ^{⁽¹²⁸⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf}
Investigator on clinical trials funded by vaccine manufacturers GlaxoSmithKline, bioCSL, Novartis and Pfizer ^{⁽¹²⁹⁾ ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf .}
Member of Asia-Pacific Alliance for the Control of Influenza (APACI) ^{⁽¹³⁰⁾ Asia-Pacific Alliance for the Control of Influenza (APACI) Members: https://www.apaci.asia/about-apaci/membership} , which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL^{⁽¹³¹⁾ Asia-Pacific Alliance for the Control of Influenza (APACI) Funding: https://www.apaci.asia/about-apaci/support-grants}
Jodie McVernon is currenty part of the Peter Doherty Institute for Infection & Immunity, COVID-19 Research team ^{⁽¹³²⁾ Doherty Institute COVID-19 Research team: https://www.doherty.edu.au/our-work/institute-themes/viral-infectious-diseases/covid-19/covid-19-research .}
Member of ATAGI’s COVID-19 Working Group ⁽¹³³⁾ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members which provides advice to the Minister for … Click for full citation.
In 2005 to 2014, Terry Nolan was appointed Chair of the Australian Technical Advisory Group on Immunisation (ATAGI) ^{⁽¹³⁴⁾ Terry Nolan Chair of ATAGI 2005-2014: https://www.who.int/immunization/sage/members/bio_nolan/en/}.
He was also appointed deputy-chair of the National Health and Medical Research Council for over 9 years ^{⁽¹³⁵⁾ MCRI / VIRGo Member Terry Nolan: https://www.mcri.edu.au/users/professor-terry-nolan} which decides the area of government research that should be funded ^{⁽¹³⁶⁾ NHMRC “Who we are”: https://www.nhmrc.gov.au/about-us/who-we-are}.
In 2009 (during his employment with ATAGI ^{⁽¹³⁷⁾ Terry Nolan Chair of ATAGI 2005-2014: https://www.who.int/immunization/sage/members/bio_nolan/en/}, Terry Nolan was the Lead Author on CSL’s funded Panvax (mono-valent H1N1) Influenza vaccine, trialled on 400 children^{⁽¹³⁸⁾ Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial: https://jamanetwork.com/journals/jama/fullarticle/185153}
He was also on the CSL Limited vaccine advisory board ^{⁽¹³⁹⁾ Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial: https://jamanetwork.com/journals/jama/fullarticle/185153}
In 2010, CSL’s Fluvax (tri-valent) Influenza vaccine was suspended for its use on children 6 months to 5 years due to its increase of febrile reactions following vaccination ⁽¹⁴⁰⁾Suspension of CSL’s Fluvax Influenza vaccine: https://www.tga.gov.au/alert/seasonal-flu-vaccine-investigation-febrile-reactions-young-children-following-2010-seasonal-trivalent-influenza-vaccination. The government inquiry was led by Terry Nolan and Peter Richmond ^{⁽¹⁴¹⁾ “A flu jab too close for comfort” The Australian, 29th Sep 2010: https://www.theaustralian.com.au/news/inquirer/a-flu-jab-too-close-for-comfort/news-story/b39e4b727923e938c93ab83b68ef1eaf} who were both on CSL’s advisory board ^{⁽¹⁴²⁾ Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial: https://jamanetwork.com/journals/jama/fullarticle/185153}. CSL was given a $131 million federal government contract to produce the nation’s entire stockpile of swine flu vaccine in 2009, half of which had to be destroyed when it passed its use-by date ^{⁽¹⁴³⁾“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s … Click for full citation}
Terry Nolan has served on a data safety monitoring board for GSK for the HPV vaccine and GSK advisory boards (unpaid) for pertussis vaccine (2014 and 2016) ^{⁽¹⁴⁴⁾ Terry Nolan vaccine manufacturer funding: https://www.sciencedirect.com/science/article/pii/S0264410X16307101?via%3Dihub#s0095 .}
Contributor of the World Health Organisation (WHO), Scientific Advisory Group of Experts (SAGE) meetings on evaluation of pandemic influenza vaccines in clinical trials each year from 2006-2011 [60].
Terry Nolan is currently part of the Peter Doherty Institute for Infection & Immunity, COVID-19 Research team^{⁽¹⁴⁵⁾ Doherty Institute COVID-19 Research team: https://www.doherty.edu.au/our-work/institute-themes/viral-infectious-diseases/covid-19/covid-19-research}.
In 2010, Terry Nolan published a report “The Australian model of immunization advice and vaccine funding”, where he states that industry sponsored vaccines are generally not considered a conflict requiring exclusion^{⁽¹⁴⁶⁾ “The Australian model of immunization advice and vaccine funding” by Terry Nolan. https://www.sciencedirect.com/science/article/pii/S0264410X10002069?via%3Dihub#section0075}

Show more (expand)

Show less (contract)

Dr Rodney PEARCE

Chairman of the Immunisation Coalition ^{⁽¹⁴⁷⁾ Immunisation Coalition Board: https://www.immunisationcoalition.org.au/about-us/} , which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google ^{⁽¹⁴⁸⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding .}
Member of the Asia-Pacific Alliance for the Control of Influenza (APACI)^{⁽¹⁴⁹⁾ Asia-Pacific Alliance for the Control of Influenza (APACI) Members: https://www.apaci.asia/about-apaci/membership}which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL ^{⁽¹⁵⁰⁾ Asia-Pacific Alliance for the Control of Influenza (APACI) Funding: https://www.apaci.asia/about-apaci/support-grants}
Member of the Working Group on a GlaxoSmithKline funded Bexsero meningococcal B vaccine trial in South Australia ^{⁽¹⁵¹⁾A Meningococcal B Program for South … Click for full citation}

Prof Peter RICHMOND

Head, Vaccine Trials Group of Telethon Kids ^{⁽¹⁵²⁾ Telethon Kids Institute, Member Peter Richmond: https://www.telethonkids.org.au/contact-us/our-people/r/peter-richmond/}, which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi ^{⁽¹⁵³⁾ Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6 .}
A member of the Influenza Specialist Group ^{⁽¹⁵⁴⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}, a government body which received funding from vaccine manufacturers Abbott, GSK, Seqirus, Pfizer, Roche and Sanofi^{⁽¹⁵⁵⁾ Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/ .}
Member of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance ^{⁽¹⁵⁶⁾ NCIRS Scientific Advisory Committee: https://www.ncirs.org.au/funding-and-governance/scientific-advisory-committee}
Was Deputy Chair of ATAGI on Immunisation 2006 to 2004 ^{⁽¹⁵⁷⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf .}
Was Chair of ATAGI “MMR Varicella and Zoster Vaccine working Party”, 2006-2014 ^{⁽¹⁵⁸⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}
Member of Immunisation Coalition ^{⁽¹⁵⁹⁾ Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google^{⁽¹⁶⁰⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding}
Has been a representative on a CSL vaccine advisory board at various times and has received nominal payments from vaccine manufacturer CSL (honoraria) ^{⁽¹⁶¹⁾ “A flu jab too close for comfort” The Australian, 29th Sep 2010: https://www.theaustralian.com.au/news/inquirer/a-flu-jab-too-close-for-comfort/news-story/b39e4b727923e938c93ab83b68ef1eaf}
Was also an investigator on the CSL funded clinical trial for Panvax vaccine in 2009 ^{⁽¹⁶²⁾ Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial:https://jamanetwork.com/journals/jama/fullarticle/185153}

As at 2019, Chair of WA Immunisation Scentific Advisory Group ^{⁽¹⁶³⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}and Chair of WA Vaccine Safety Advisory Committee^{⁽¹⁶⁴⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}
He was co-author of the Western Australian Influenza Vaccine Efficacy trial (WAIVE) for children in WA (2008 –2015) ^{⁽¹⁶⁵⁾ Peter Richards co-author of WAIVE trial: https://www.telethonkids.org.au/our-research/reports-and-findings/2010/july/lessons-from-the-first-year-of-the-waive-study-investigating-the-protective-effect-of-influenza-vaccine/} which at the time was funded by vaccine manufacturers CSL, Sanofi–Pasteur and WA Health Dept in 2008 (announced by Government of Western Australia, Department of Health, Media Release 15th Feb 2008, Free vaccines to help fight child influenza – which is no longer available). However, WAVE trial is currently with Telethon Kids ^{⁽¹⁶⁶⁾ WAIVE Vaccine Trial conducted by Telethon Kids: https://infectiousdiseases.telethonkids.org.au/our-research/vaccine-trials-group/current-studies/waive/ ,} which is partnered with Johnson & Johnson, Roche, Pfizer, Novartis, GSK and Sanofi ^{⁽¹⁶⁷⁾ Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6 .}
Served on scientific advisory boards for Sanofi (influenza vaccine), GSK (maternal immunisation), AstraZeneca (influenza vaccine) ^{⁽¹⁶⁸⁾ “The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Paris”, 2012-2015: https://academic.oup.com/cid/article/68/3/402/5202330 .}
Served on vaccine scentific advisory groups for GlaxsoSmith Kline (pertussis), Pfizer (pneumococcal conjugate vaccines), Baxter (mengingococcal C conjugate & ross river virus vaccine) and Murdoch Children’s Research Institute (rotavirus RV3 D5MB) ^{⁽¹⁶⁹⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}
Principal Investigator of industry sponsored multi-centre studies for Baxter, CSL, GlaxsoSmithKline, Medimmune, Merck, Pfizer, Sanofi and Novartis^{⁽¹⁷⁰⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}
Received research funding for investigator initiated studies from GlaxoSmithKline, Merck, and Novartis ^{⁽¹⁷¹⁾ Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf}

Show more (expand)

Show less (contract)

Prof Bruce ROBINSON

Chairperson of the Council of National Health & Medical Research Council (NHMRC)^{⁽¹⁷²⁾ Chairperson of NHMRC Bruce Robinson: https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/members-council-2018-2021-triennium} , who was formerly on the Advisory Board for AstraZeneca and Bayer Australia ⁽¹⁷³⁾Bruce Robinson of AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675689/ . The Immunisation Handbook is approved NHMRC ^{⁽¹⁷⁴⁾ Immunisation Handbook advices on vaccines: https://immunisationhandbook.health.gov.au/}

Kim SAMPSON

CEO of the Immunisation Coalition ^{⁽¹⁷⁵⁾ Kim Sampson CEO of Immunisation Coaltion: https://www.immunisationcoalition.org.au/news-media/latest-data-shows-australians-are-keen-to-protect-themselves-from-influenza-this-year/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google ^{⁽¹⁷⁶⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding}
Executive Director of the Asia-Pacific Alliance for the Control of Influenza (APACI)^{⁽¹⁷⁷⁾ Asia-Pacific Alliance for the Control of Influenza (APACI) Kim Sampson: https://www.apaci.asia/about-apaci/apaci-management}which has received funds from vaccine manufacturers IFPMA, Roche and Seqirus/CSL ^{⁽¹⁷⁸⁾ Asia-Pacific Alliance for the Control of Influenza (APACI) Funding: https://www.apaci.asia/about-apaci/support-grants}

Dr Tom SNELLING

Member of PBS/PBAC ^{⁽¹⁷⁹⁾ PBS Membership: https://www.pbs.gov.au/info/industry/listing/participants/pbac}, which receives funds from Cost Recovery Fees & Charges from vaccine manufacturers ^{⁽¹⁸⁰⁾ The Pharmaceutical Benefits Scheme Funding: https://www.pbs.gov.au/info/industry/listing/elements/fees-and-charges#Background-on-cost-recovery-for-PBS-and-NIP-listings .}
Member of ATAGI ^{⁽¹⁸¹⁾ ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members}
Member of the Scientific Advisory Committee for National Centre for Immunisation Research & Surveillance ^{⁽¹⁸²⁾ NCIRS Scientific Advisory Committee: https://www.ncirs.org.au/funding-and-governance/scientific-advisory-committee .}
Head, Infectious Disease Implementation at Telethon Kids ^{⁽¹⁸³⁾ Telethon Kids, Member Tom Snelling: https://www.telethonkids.org.au/contact-us/our-people/s/tom-snelling/}, which is partnered with vaccine manufacturers GSK, Johnson & Johnson, Novartis, Pfizer, Roche, and Sanofi ^{⁽¹⁸⁴⁾ Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6}
Former investigator on pneumococcal vaccine for the National Immunisation Program ^{⁽¹⁸⁵⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Investigator on Pertussis vaccine ^{⁽¹⁸⁶⁾ ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf}
Member of ATAGI’s COVID-19 Working Group^{⁽¹⁸⁷⁾ ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members} which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia.

Show more (expand)

Show less (contract)

Prof Paul VAN BUYNDER

Member of the Immunisation Coalition ^{⁽¹⁸⁸⁾ Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/}, which is funded by vaccine manufacturers Pfizer, CSL/Seqirus, GlaxoSmithKline, Sanofi and Merck, and Google ^{⁽¹⁸⁹⁾ Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding}
In January 2020 he expressed “pushing anti-vax views should be criminal offence”^{⁽¹⁹⁰⁾ Paul Van Buynder speaks out against anit-vaxxers: PDF .}

The Informed Medical Options Party keeps updated list of Australian Vaccination Policies

Download Research

See All COVID Posts

Site Notifications/Chat:

Telegram Post Updates @JourneyToABetterLife (channel)
Telegram Chatroom @JourneyBetterLifeCHAT (say hi / share info)
Gettr Post Updates @chesaus (like fakebook)

Videos:

Aussies

Reveal PayID 323

Or Buy me a Coffee (PayPal)

References[+]

References
01, 11, 16, 58, 159, 188	Immunisation Coalition Members: https://www.immunisationcoalition.org.au/about-us/
02, 12, 17, 28, 59, 148	Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding
03	Katie Attwell of “I Immunise” Campaign: https://theconversation.com/vaccinations-are-a-vital-part-of-ethical-alternative-lifestyles-22385
04	Kristine Macartney Director of NCIRS: http://www.ncirs.org.au/our-people/executive-management-team
05	ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf
06	ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members
07	ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf
08	ATAGI’s Pertussis Working Party: https://www.health.gov.au/sites/default/files/pertussis-working-party.pdf
09	ATAGI’s HPV Working Party: https://www.health.gov.au/sites/default/files/hpv-working-party.pdf
10	ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members
13	Doherty Institute, Ian Barr: https://www.doherty.edu.au/people/dr-ian-barr “35 years experience in biological research and development in academic institutions and at ACSL on various topics such as vaccine development
14, 100	Previous Advisory Group of Experts for WHO Consultations on the Composition of Influenza Virus Vaccines: https://proxy-redirect.netlify.app/influenza/vaccines/virus/temporary_advisors_home/en/
15	AMA Board Members: https://ama.com.au/board
18, 35, 56, 125	ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf
19	Telethon Kids Institute, Co-Director: https://www.telethonkids.org.au/contact-us/our-people/b/christopher-blyth/
20, 167	Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6
21, 72, 187	ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members
22, 37	ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members
23, 38, 41, 43, 73, 74	ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf
24	Meningococcal Aust Advisor Robert Booy: http://www.meningococcal.org.au/support
25	Meningococcal Aust funding: http://www.meningococcal.org.au/support
26	Robert Booy Head of NCIRS: https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/robert-booy.html (note: web link has since been removed) – see ref [54] – impparty
27, 147	Immunisation Coalition Board: https://www.immunisationcoalition.org.au/about-us/
29, 30	Robert Booy vaccine manufacturer funding: https://www.sciencedirect.com/science/article/pii/S0264410X16307101?via%3Dihub#s0095
31, 67, 77, 93, 115	Friends of Science (FSM) Members: https://www.scienceinmedicine.org.au/who-are-we/who-are-our-friends/our-friends/
32, 68, 94, 116	Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings
33	Department of Health research group for HPV vaccine: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-cdi-2004-cdi2802-htm-cdi2802p.htm
34, 36	Allen Cheng at Alfred Health: https://www.alfredhealth.org.au/find-a-doctor/bio/dr-allen-cheng
39, 55	ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members
40	Deputy Chief Health Officer of Victoria, Allen Cheng: https://www.parliament.vic.gov.au/paec/inquiries/article/4554
42	ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf
44	ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf
45	Govt announcement $1.7M to Allen Cheng: https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/press-conference-in-melbourne-about-covid-19
46	Peter Costello Chairman of Future Fund: https://www.futurefund.gov.au/about-us/who-we-are/board-of-guardians
47	Futurefund Investors as at June 2020: https://www.futurefund.gov.au/-/media/future-fund—documents/largest-listed-equity-holdings/20200630—top-100-largest-listed-equity-holdings.ashx?la=en&hash=AA01CDFBEAA52A0D939137EDC9FA55B1969BA317
48	Peter Costello Chairman of Nine Entertainment Co: https://www.news.com.au/finance/peter-costello-becomes-chairman-of-nine-entertainment/news-story/92f3dfd6cc3386e49b3855640f07c767
49	Nine Entertainment Newspapers: https://www.nineforbrands.com.au/ad-specs/print-and-magazines/
50	Sydney Morning Herald “Anti-vaxxer movement”: https://www.smh.com.au/topic/anti-vaxxer-movement-1mnk
51, 54	Nigel Crawford Group Leader at MCRI: https://www.mcri.edu.au/users/dr-nigel-crawford
52, 64, 65	Murdoch Children’s Research Institute Funding & collaboration through VIRGo: https://www.mcri.edu.au/research/themes/infection-and-immunity/vaccine-and-immunisation-research-group-virgo Click on “Funding & Collaborations” for funding
53, 113, 122	ATAGI Conflicts of Interest – 2015 document (now removed from ATAGI website) – Download PDF from imoparty.com
57	Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/
60	MCRI Member Margie Danchin : https://www.mcri.edu.au/users/dr-margaret-danchin
61	Margie Danchin promoting COVID-19 vaccination: https://theconversation.com/covid-19-vaccines-could-go-to-children-first-to-protect-the-elderly-147899
62	Doherty Institute named after Peter Doherty: https://www.doherty.edu.au/about/overview
63	Peter Doherty: https://www.doherty.edu.au/about/laureate-professor-peter-doherty
66	Doherty Institute provides modelling for COVID-19 response: https://www.doherty.edu.au/news-events/news/covid-19-modelling-papers
69	Katie Flanagan affiliated with Monash University: https://katieflanagan.net/profile
70	Katie Flanagan grant funding: https://katieflanagan.net/research-grants
71, 185, 186	ATAGI Conflict of Interest (Sep 2020): https://www.health.gov.au/sites/default/files/documents/2020/09/atagi-declarations-of-interest.pdf
75	CSL manufacturer of Gardasil vaccine: https://www.epo.org/news-events/events/european-inventor/finalists/2015/frazer.html
76	Ian Frazer receives royalties from Gardasil: https://theconversation.com/catch-cancer-no-thanks-id-rather-have-a-shot-7568
78	Friends of Science Submission to No Jab No Pay bill at the Senate Hearing in Nov 2015: https://www.aph.gov.au/Parliamentary_Business/Committees/Senate/Community_Affairs/No_Jab_No_Pay/Public_Hearings
79	National COVID-19 Commission (Advisory Board) Commissioners and Key Staff – Jane Halton https://www.pmc.gov.au/ncc/who-we-are
80	Chair of CEP – Jane Halton – https://cepi.net/about/whoweare/
81	CEPI funds Novavax: https://novavax.com/about-us#our-partners
82	Novovax being trialed in Australia – https://www.nejm.org/doi/full/10.1056/NEJMoa2026920?query=featured_home
83	Jane Halton radio interview pushing for COVID No Jab No Play: https://www.4bc.com.au/push-from-medical-experts-to-make-future-covid-19-vaccine-compulsory/
84	Jane Halton Director of Crown Resorts: https://www.crownresorts.com.au/About-Us/Board-of-Directors
85	Crown Resort COVID quarantine facility in VIC: https://www.theage.com.au/national/victoria/high-security-as-international-arrivals-to-melbourne-taken-to-crown-for-quarantine-20200329-p54ex1.html
86	Trevor Sutton at ABS: http://www.healthdata.org/about/trevor-sutton
87	Jane Halton on Board of IHME: http://www.healthdata.org/about/governance/board
88	IHME and Bill & Melinda Gates Foundation: http://www.healthdata.org/about/history Refer to 2007
89	ABS awarded to Accenture: https://www.govtechreview.com.au/content/gov-tech/news/abs-engages-accenture-for-improved-data-collection-511127082
90	Accenture & ID2020 agenda with GAVI: https://id2020.org/alliance
91	David Hawkes Director of VCS: https://www.vcs.org.au/about-us/executive-team/dr-david-hawkes/
92	VCS funed by NHMRC: https://www.vcs.org.au/
95	PHAA 2014 Conference, promoting SAVN
96	Transcript “No Jab, No Pay” Senate Inquiry Hearing in 2015
97	Members of Stop the AVN [SAVN] – Patrick Stokes, Submission at No Jab No Play Senate Inquiry 2015 – PDF
98	World Health Organisation (WHO), Anne Kelso: https://www.who.int/influenza/gisrs_laboratory/collaborating_centres/collabcentres/en/
99	NHMRC, Anne Kelso: https://www.nhmrc.gov.au/about-us/leadership-and-governance/senior-executive-and-leadership-team
101	“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s sole manufacturer of flu vaccines.” https://web.archive.org/web/20110908195013/http://www.theaustralian.com.au/national-affairs/flu-adviser-defends-csl-shares/story-fn59niix-1226131711216
102, 103	“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s sole manufacturer of flu vaccines.” https://web.archive.org/web/20110908195013/http://www.theaustralian.com.au/national-affairs/flu-adviser-defends-csl-shares/story-fn59niix-1226131711216
104	AMA’s President Dr Omar Khorshid: https://ama.com.au/about/board
105	Immunisation Coalition’s Network: https://www.immunisationcoalition.org.au/our-network/
106	Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding
107	AMA’s President Dr Omar Khorshid article on COVID vaccination: https://www.theaustralian.com.au/breaking-news/ama-president-omar-khorshid-on-australias-only-way-to-stay-covid-free/news-story/2003d28a98a48071616f7a26f0837486
108, 112, 182	NCIRS Scientific Advisory Committee: https://www.ncirs.org.au/funding-and-governance/scientific-advisory-committee
109, 168	“The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Paris”, 2012-2015: https://academic.oup.com/cid/article/68/3/402/5202330
110	“South Australia leads nation with Australian-first Meningococcal B study” The University of Adelaide, 13th Dec 2016: https://www.adelaide.edu.au/news/news89822.html
111, 151	A Meningococcal B Program for South Australia:https://www.sahealth.sa.gov.au/wps/wcm/connect/b82a9fb7-061a-48b9-be37-54e88a1907d1/2018-06+Optimal+Men+B+Program+for+SA+Public+Report+%282%29.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-b82a9fb7-061a-48b9-be37-54e88a1907d1-n5iiiDg
114	“The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Paris”, 2012-2015: https://academic.oup.com/cid/article/68/3/402/5202330
117	Former Director of NCRIS, Peter McIntyre: https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-cdieab-bio-mcintyre.htm
118	Peter McIntyre ex-officio member of ATAGI: https://www.who.int/immunization/sage/meetings/bio_mcintyre/en/
119, 124	ATAGI’s Pertussis Working Party: https://www.health.gov.au/sites/default/files/pertussis-working-party.pdf
120	ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/default/files/influenza-working-party.pdf
121	Planning for human papillomavirus vaccines in Australia, Peter McIntyre: https://www1.health.gov.au/internet/main/publishing.nsf/content/cda-pubs-cdi-2004-cdi2802-htm-cdi2802p.htm
123	ATAGI’s Influenza Working Party (2018): https://www.health.gov.au/sites/def a ult/files/influenza-working-party.pdf
126	Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/
127, 128, 129	ATAGI Conflict of Interest (early 2020): https://www.health.gov.au/sites/default/files/atagi-conflict-of-interest-disclosures.pdf
130	Asia-Pacific Alliance for the Control of Influenza (APACI) Members: https://www.apaci.asia/about-apaci/membership
131, 150, 178	Asia-Pacific Alliance for the Control of Influenza (APACI) Funding: https://www.apaci.asia/about-apaci/support-grants
132, 145	Doherty Institute COVID-19 Research team: https://www.doherty.edu.au/our-work/institute-themes/viral-infectious-diseases/covid-19/covid-19-research
133	ATAGI’s COVID-19 Working Group: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi-covid-19-working-group#atagi-covid19-working-group-members which provides advice to the Minister for Health on the immunisation program for COVID-19 vaccines as they become available in Australia. Show more (expand) Show less (contract) Prof Terry NOLAN Currently Head of Vaccination and Immunisation Research Group (VIRGo), which he established in the 1990’s [57] at the Murdoch Children’s Research Institute, which has received funding from vaccine manufacturers GSK, Janssen, Merck, Novavax, Sanofi and Sequiris ^{(( Murdoch Children’s Research Institute Funding & collaboration through VIRGo: https://www.mcri.edu.au/research/themes/infection-and-immunity/vaccine-and-immunisation-research-group-virgo Click on “Funding & Collaborations” for funding}
134, 137	Terry Nolan Chair of ATAGI 2005-2014: https://www.who.int/immunization/sage/members/bio_nolan/en/
135	MCRI / VIRGo Member Terry Nolan: https://www.mcri.edu.au/users/professor-terry-nolan
136	NHMRC “Who we are”: https://www.nhmrc.gov.au/about-us/who-we-are
138, 139	Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial: https://jamanetwork.com/journals/jama/fullarticle/185153
140	Suspension of CSL’s Fluvax Influenza vaccine: https://www.tga.gov.au/alert/seasonal-flu-vaccine-investigation-febrile-reactions-young-children-following-2010-seasonal-trivalent-influenza-vaccination
141	“A flu jab too close for comfort” The Australian, 29th Sep 2010: https://www.theaustralian.com.au/news/inquirer/a-flu-jab-too-close-for-comfort/news-story/b39e4b727923e938c93ab83b68ef1eaf
142	Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial: https://jamanetwork.com/journals/jama/fullarticle/185153
143	“Flu adviser defends CSL shares”, The Australian, 8th Sep 2011: Anne Kelso “A GOVERNMENT immunisation adviser in charge of a World Health Organisation influenza laboratory owns shares in Australian pharmaceutical giant CSL, the nation’s sole manufacturer of flu vaccines.” https://web.archive.org/web/20110908195013/http://www.theaustralian.com.au/national-affairs/flu-adviser-defends-csl-shares/story-fn59niix-1226131711216
144	Terry Nolan vaccine manufacturer funding: https://www.sciencedirect.com/science/article/pii/S0264410X16307101?via%3Dihub#s0095
146	“The Australian model of immunization advice and vaccine funding” by Terry Nolan. https://www.sciencedirect.com/science/article/pii/S0264410X10002069?via%3Dihub#section0075
149	Asia-Pacific Alliance for the Control of Influenza (APACI) Members: https://www.apaci.asia/about-apaci/membership
152	Telethon Kids Institute, Member Peter Richmond: https://www.telethonkids.org.au/contact-us/our-people/r/peter-richmond/
153	Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6
154, 157, 158, 163, 164, 169, 170, 171	Health Ed Immunisation Update Declaration of COI on Peter Richmond: https://www.healthed.com.au/wp-content/uploads/2019/08/PWCH16-Peter-Richmond.pdf
155	Influenza Specialist Group (ISG) Sponsors: http://www.isg.org.au/index.php/about/sponsorship-and-support/
156	NCIRS Scientific Advisory Committee: https://www.ncirs.org.au/funding-and-governance/scientific-advisory-committee
160, 176, 189	Immunisation Coalition Funding: https://www.immunisationcoalition.org.au/about-us/ go to: Funding
161	“A flu jab too close for comfort” The Australian, 29th Sep 2010: https://www.theaustralian.com.au/news/inquirer/a-flu-jab-too-close-for-comfort/news-story/b39e4b727923e938c93ab83b68ef1eaf
162	Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children, A Randomized Trial:https://jamanetwork.com/journals/jama/fullarticle/185153
165	Peter Richards co-author of WAIVE trial: https://www.telethonkids.org.au/our-research/reports-and-findings/2010/july/lessons-from-the-first-year-of-the-waive-study-investigating-the-protective-effect-of-influenza-vaccine/
166	WAIVE Vaccine Trial conducted by Telethon Kids: https://infectiousdiseases.telethonkids.org.au/our-research/vaccine-trials-group/current-studies/waive/
172	Chairperson of NHMRC Bruce Robinson: https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/members-council-2018-2021-triennium
173	Bruce Robinson of AstraZeneca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675689/
174	Immunisation Handbook advices on vaccines: https://immunisationhandbook.health.gov.au/
175	Kim Sampson CEO of Immunisation Coaltion: https://www.immunisationcoalition.org.au/news-media/latest-data-shows-australians-are-keen-to-protect-themselves-from-influenza-this-year/
177	Asia-Pacific Alliance for the Control of Influenza (APACI) Kim Sampson: https://www.apaci.asia/about-apaci/apaci-management
179	PBS Membership: https://www.pbs.gov.au/info/industry/listing/participants/pbac
180	The Pharmaceutical Benefits Scheme Funding: https://www.pbs.gov.au/info/industry/listing/elements/fees-and-charges#Background-on-cost-recovery-for-PBS-and-NIP-listings
181	ATAGI Members: https://www.health.gov.au/committees-and-groups/australian-technical-advisory-group-on-immunisation-atagi#members
183	Telethon Kids, Member Tom Snelling: https://www.telethonkids.org.au/contact-us/our-people/s/tom-snelling/
184	Telethonkids Investors: https://www.telethonkids.org.au/globalassets/media/documents/annual-reports/impact-report-2019.pdf Page 6
190	Paul Van Buynder speaks out against anit-vaxxers: PDF

Penny... on Health

Truth-seeker, ever-questioning, ever-learning, ever-researching, ever delving further and deeper, ever trying to 'figure it out'. This site is a legacy of sorts, a place to collect thoughts, notes, book summaries, & random points of interests.

DISCLAIMER: The information on this website is not medical science or medical advice. I do not have any medical training aside from my own research and interest in this area. The information I publish is not intended to diagnose, treat, cure or prevent any disease, disorder, pain, injury, deformity, or physical or mental condition. I just report my own results, understanding & research.

View my other posts